News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
How Repurposing a Drug May Help Treat More Rare Gastrointestinal Diseases
June 29, 2026 - NCATS News
- Rare Diseases Clinical Research Network (RDCRN)
RDCRN researchers found that dupilumab — a drug used for asthma and chronic obstructive pulmonary disease — shows promise in treating eosinophilic gastritis.
Read Article
FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder
May 21, 2026 - NCATS News
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
MMA-101, an NIH-supported AAV gene therapy for a rare metabolic disorder, has received FDA clearance to begin clinical testing.
Read ArticleMore Than 30 Million Americans Living With Rare Diseases
February 23, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Rare Diseases Clinical Research Network Awardees Expand the Reach of NIH Impact
February 5, 2026 - NCATS News
- Rare Diseases Clinical Research Network (RDCRN)
NIH awarded funding to 10 new and five continuing Rare Diseases Clinical Research Network (RDCRN) consortia to help address challenges in rare diseases treatment development.
UNC Researchers Awarded $7.3 Million to Advance Research on Rare Bronchiectatic Diseases
February 4, 2026 - Grantee/Partner News
- Rare Diseases Clinical Research Network (RDCRN)
A Rare Respiratory Disease May Be More Prevalent in Quebec
November 27, 2025 - Grantee/Partner News
- Rare Diseases Clinical Research Network (RDCRN)
NIH Awards Baylor More Than $15 Million to Fund Two Rare Diseases Consortia
September 30, 2025 - Grantee/Partner News
- Rare Diseases Clinical Research Network (RDCRN)
NIH Awards $15M+ to Baylor-Led Consortia Targeting Rare Bone and Metabolic Disorders
September 27, 2025 - Media Coverage
- Rare Diseases Clinical Research Network (RDCRN)